Institution
King Chulalongkorn Memorial Hospital
Also known as: โรงพยาบาลจุฬาลงกรณ์ · KCMH
- 48running trials
- 42closed trials
- 8,479publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Recruiting
Recruiting
Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
Recruiting
Enrolling by invitation
Recruiting
Recruiting
Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors
Recruiting
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Demographic and Interpopulation Variations in Evaluation and Results of TAVI
Recruiting
Active, not recruiting
Recruiting
Recruiting
Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Enrolling by invitation
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Active, not recruiting
Active, not recruiting
A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A
Recruiting
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes4 recruiting
- Childhood cancers3 recruiting
- Myelodysplastic syndromes3 recruiting
- Obesity3 recruiting
- ALS (motor neurone disease)2 recruiting
- Chronic kidney disease2 recruiting
- Thalassaemia2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Alzheimer disease1 recruiting
- Aortic stenosis1 recruiting
- Bronchiectasis1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Diabetic neuropathy1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Haemophilia1 recruiting
- High blood pressure1 recruiting
- HIV1 recruiting
- Lung cancer1 recruiting
- Macular degeneration1 recruiting
- Multiple myeloma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Stroke1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
The Efficacy of Aerobic Exercise Training on ANS and Endothelial Function in Compensated Cirrhosis
Withdrawn
Completed
Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.
Recruiting
Completed
Withdrawn
Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Completed
Completed
A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Terminated
Completed
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
Completed
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Completed
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
Terminated
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
Completed
Completed
Completed
Completed
Completed
Registry name variants (29)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
King Chulalongkorn Memorial Hospital
Bangkok, 10330
43 trials
King Chulalongkorn Memorial Hospital
Pathum Wan, Bangkok 10330
10 trials
King Chulalongkorn Memorial Hospital_Endocrinology
Bangkok, 10330
5 trials
King Chulalongkorn Memorial Hospital
Pathumwan, 10330
3 trials
Contact: Jeerath Phannajit M.D.
NCT03940703A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
King Chulalongkorn Memorial Hospital
Patumwan, Bangkok 10330
3 trials
Contact: Boehringer Ingelheim
King Chulalongkorn Memorial Hospital_Bangkok
Bangkok, 10330
3 trials
King Chulalongkorn Memorial Hospital (Chulalongkorn University)
Bangkok, 10330
3 trials
Chulalongkorn University Faculty of Medicine - King Chulalongkorn Memorial Hospital
Bangkok, 10330
2 trials
NCT04143724Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Contact: Darintr Sosothikul, Site 503
Contact: Pranee Sutcharitchan, Site 800
King Chulalongkorn Memorial hospital, The Thai Red Cross Society
Pathum Wan, Bangkok 10330
2 trials
NCT07195045Thai PainPREDICT Validation Study
Contact: Jakkrit Amornvit, MD
NCT07175935Amyotrophic Lateral Sclerosis Registry in Thailand
Contact: Jakkrit Amornvit, MD
The Faculty of Medicine, Chulalongkorn University/ King Chulalongkorn Memorial Hospital
Pathum Wan, Bangkok 10330
2 trials
NCT06484335RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
Contact: Carlo Sacdalan, MD, MBA, MSc
NCT05769569Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission
7640010 - King Chulalongkorn Memorial Hospital
Pathum Wan, 10330
1 trial
Chulalongkorn University - Faculty of Medicine - King Chulalongkorn Memorial Hospital (KCMH)
Bangkok, 10300
1 trial
Chulalongkorn University, King Chulalongkorn Memorial Hospital
Bangkok, 10330
1 trial
Chulaneuroscience Center, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society
Bangkok, 10330
1 trial
Faculty of medicine, King Chulalongkorn Memorial Hospital
Bangkok, Bangkok 10330
1 trial
King Chulalongkorn Memorial Hospital_Bangkok_0
Bangkok, 10330
1 trial
King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Bangkok
1 trial
King Chulalongkorn Memorial Hospital_Cardiology
Bangkok, 10330
1 trial
King Chulalongkorn Memorial Hospital, Chulalongkom University
Bangkok, 10330
1 trial
King Chulalongkorn Memorial Hospital-Division of Nephrology
Bangkok, 10330
1 trial
King Chulalongkorn Memorial Hospital (KCMH)
Bangkok
1 trial
Contact: Principal Investigator
King Chulalongkorn Memorial Hospital - Neurology
Bangkok, 10330
1 trial
King Chulalongkorn Memorial Hospital_Obstetrics&Gynecology
Bangkok, 10330
1 trial
King Chulalongkorn Memorial Hospital; Ophthalmology Department
Bangkok, 10330
1 trial
King Chulalongkorn Memorial Hospital_Pediatric Hematology-Oncology
Bangkok, 10330
1 trial
King Chulalongkorn Memorial Hospital_Ped-Nutrition
Bangkok, 10300
1 trial
Contact: Novo Nordisk
King Chulalongkorn Memorial Hospital (Site 0884)
Bangkok, Bangkok 10330
1 trial
King Chulalongkorn Memorial hospital, The Thai Red Cross Society
Bangkok, Pathumwan 10330
1 trial
NCT07067229Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
Contact: Jakkrit Amornvit, MD
King memorial Chulalongkorn hospital
Bangkok, Bangkok 10330
1 trial
NCT05350865Thailand HDV Cohort
Conditions
Diseases this institution publishes on or runs trials for.
- Familial hypercholesterolaemia9 works · 1 trial
- Multiple system atrophy3 works · 0 trials
Institution data: ROR 05jd2pj53 (CC0-1.0)Updated 15 Nov 2026